학술논문
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
Document Type
Article
Author
Source
In: Movement Disorders . (Movement Disorders, February 2024, 39(2):350-359)
Subject
Language
English
ISSN
15318257
08853185
08853185